Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2021

Nov 23, 2021

30071_dirs_2021-11-22_fcdc8677-df0a-4030-adbb-1d172c73522e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2021-11-18

Reporting Person: Burt Carol (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-18 ResMed Common Stock A 956 Acquired 15551 Direct

Footnotes

F1: Corrects number of securities beneficially owned after reported award.